A study published in Neurotherapeutics dives into the role of the gut microbiome in the pathogenesis and progression of multiple sclerosis (MS), a chronic autoimmune disorder of the central nervous system. As researchers investigate how gut-mediated immune modulation may impact neurological outcomes, probiotics and fecal microbiota transplantation (FMT) have garnered interest as potential adjunctive therapies.
Initial probiotic interventions in MS have…
Continue Reading
News Source: www.labroots.com

Leave a Reply